Dexnaaf 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Naafco pharma ltd |
Also available as |
Indications
- Healing of Erosive Esophagitis
- Maintenance of Healed Erosive Esophagitis
- Symptomatic Non-Erosive Gastroesophageal Reflux Disease
Pharmacology
- Proton Pump Inhibitor
- Suppression of Gastric Acid Secretion
- Specific Inhibition of (H+/K+)-ATPase
- Dual Delayed Release (DDR) Formulation
Dosage
- 30 mg Once daily for Maintenance of Healed erosive esophagitis and relief of heartburn
- 30 mg Once daily for Symptomatic Non-Erosive GERD
- 60 mg Once daily for Healing of erosive esophagitis
- 30 mg tablet once daily for Maintenance of healed erosive esophagitis and relief of heartburn (MUPS)
- 30 mg tablet once daily for Symptomatic Non-Erosive GERD (MUPS)
Administration
- Can be taken without regard to food
- Swallowed whole
- Granules can be sprinkled on one tablespoon and swallowed immediately
Interaction
- Potential interaction with Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate
Contraindications
- Known hypersensitivity to any component of the formulation
Side Effects
- Diarrhea
- Abdominal pain
- Nausea
- Vomiting
- Flatulence
Pregnancy & Lactation
- Pregnancy Category B
Precautions & Warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone fracture
- Hypomagnesemia
- Concomitant use with Methotrexate
Use in Special Populations
- Safety and effectiveness in patients below 12 years of age not established
- No dose adjustment necessary for elderly patients
- No dose adjustment necessary for patients with renal impairment
- No dose adjustment necessary for patients with mild hepatic impairment
- Consider maximum daily dose of 30 mg for patients with moderate hepatic impairment
Overdose Effects
- No reports of significant overdose
- Multiple doses of 120 mg and a single dose of 300 mg did not result in severe adverse events
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Store below 30°C in a dry place, protected from light
Related Brands
- Dexilend 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexilend 60 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexlan 30 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Dexlan 60 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Desopra 30 mg (Capsule (Enteric Coated)) - alco-pharma-ltd